Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › vorapaxar

vorapaxar

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of vorapaxar

8 trials tracked of vorapaxar: 5 in phase 3 or 4 and 2 with published results. The most-cited published study has 22 citations.

8Trials tracked
5Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 4 Phase 3 1 Phase 2 3
  1. Phase 4 Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor Completed · 22 cited
  2. Phase 4 Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus Completed · 19 cited
  3. Phase 4 Vorapaxar in the Human Endotoxemia Model Completed
  4. Phase 4 Vorapaxar on Thrombin Generation and Coagulability Completed
  5. Phase 3 Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737) Completed
  6. Phase 2 Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016) Completed
Show 2 more trials
  1. Phase 2 Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints Completed
  2. Phase 2 Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.